Healthcare >> Analyst Interviews >> June 27, 2011

Hitech Act Benefits Companies Levered To Ehr & Rcm – Stephen Shankman – Ubs Investment Bank

Stephen Shankman joined UBS Investment Bank in 2010 as an Analyst on the health care distribution and technology team. Previously, Mr. Shankman worked at Natixis Bleichroeder LLC as a sell-side Research Analyst covering the health care services sector, and prior to that he worked as part of the large pharma and biotech team, also at Natixis. Before joining Natixis, he worked on the buy side at Sanford C. Bernstein & Co., and at a small investment manager in a research capacity. He holds a B.A. from the University of Michigan and an MBA in finance from the New York University Leonard N. Stern School of Business. Profile
TWST: Please begin with a brief overview of your coverage areas, including some of the specific names you follow.

Mr. Shankman: I am an Analyst on the UBS health care distribution and IT equity